This website is a collection of information on various topics. We try to collect information on topics that are important to those searching for information on the internet. We hope that you find the information here useful.
With the current harvest of cucumbers and fresh salad greens, vinegar is used by local cooks, to bring out the best in these vegetables. It’s also time to make pickles and pickled beets, which could not be accomplished without this pungent liquid. […]
Peter Barry Lawrence pointed a BB gun at a bank teller and was surprised at the amount of bravado that surged through him. He threatened to shoot anyone who followed him out. […]
I found myself thinking about posterity the other day, while watching a carousel of china dogs self-destruct. The provoking object was Joana Vasconcelos's artwork Passarelle (Catwalk), part of her exhibition at the Haunch of Venison Gallery in London and – in an exhibition that put up some stiff competition in this category – by some stretch the most ca […]
Regeneron Reports Second Quarter 2010 Financial and Operating ResultsPR-CANADA.net (press release)ARCALYST® is in a Phase 3 clinical development program for the prevention of gout flares in patients initiating uric acid-lowering therapy. ...Astellas to Pay $295 Million to Extend License of Regeneron's VelocImmune ...PR-CANADA.net (press release)REGN […]
Robber says he did it to go back to prisonSan Diego Union TribuneSeeking out treatment for diabetes, colon cancer, Parkinson's disease, gout, heart disease and glaucoma has just become too much for him to handle on his ...and more » […]
MIMS bulletin to highlight musculoskeletal drug 'firsts'Healthcare Republic... drug launches in the musculoskeletal field, including the first therapeutic antibody for osteoporosis and the first new gout treatment for 40 years. ... […]
Clinical Trials Update: July 29, 2010MSN Health & FitnessThis study is evaluating an investigational drug in people with gout and heart disease. Participants will receive study-related exams, labs, and study drug ... […]
Genetic Engineering NewsRegeneron Reports Second Quarter 2010 Financial and Operating ResultsPR Newswire (press release)ARCALYST® is in a Phase 3 clinical development program for the prevention of gout flares in patients initiating uric acid-lowering therapy. ...Regeneron Banking $165M on Expanded Astellas AgreementBioWorld OnlinePharma Watch: Regeneron, Ast […]